Overview

Bioequivalence Study of AJU-R713 and R713R in Healthy Adult Volunteers

Status:
NOT_YET_RECRUITING
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
To Evaluate the Safety and Pharmacokinetics of Pranlukast hydrate in Healthy Adults.
Phase:
PHASE1
Details
Lead Sponsor:
AJU Pharm Co., Ltd.
Treatments:
Drug Evaluation